Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
JAMA Ophthalmology|August 18, 2022
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over TimeDennis M Marcus, Paolo S Silva, Danni Liu, et al.
JAMA Ophthalmology|August 18, 2022
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over TimePaolo S Silva, Dennis M Marcus, Danni Liu, et al.
Cerebral Circulation - Cognition and Behavior|April 13, 2026
Associations between retinal microvasculature and cognition in middle-aged adults with type 1 diabetes without overt neurological symptomsIiris Kyläheiko, Aleksi Tarkkonen, Linda Kuusela, et al.
Ophthalmology|May 14, 2021
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AHClement K Chan, Calvin E Mein, Adam R Glassman, et al.
Ophthalmology. Retina|October 10, 2021
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)Judy E Kim, Adam R Glassman, Kristin Josic, et al.
Translational Vision Science & Technology|December 30, 2021
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography InstrumentsJennifer K Sun, Kristin Josic, Michele Melia, et al.
Lancet (London, England)|January 27, 2022
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trialsCharles C Wykoff, Francis Abreu, Anthony P Adamis, et al.
JAMA Ophthalmology|July 26, 2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical TrialJeffrey G Gross, Adam R Glassman, Danni Liu, et al.
Ophthalmology Science|May 1, 2026
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)Andrew J Barkmeier, Thu P Vu, Michael Elman, et al.
Ophthalmology|January 14, 2026
Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results From the RHONE-X Extension TrialVeeral S Sheth, Patricio Schlottmann, Timothy Y Y Lai, et al.
Pageof 17